These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 31667754)

  • 1. Pathogenic Mechanisms and Therapy Development for C9orf72 Amyotrophic Lateral Sclerosis/Frontotemporal Dementia.
    Jiang J; Ravits J
    Neurotherapeutics; 2019 Oct; 16(4):1115-1132. PubMed ID: 31667754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels.
    Beckers J; Tharkeshwar AK; Van Damme P
    Autophagy; 2021 Nov; 17(11):3306-3322. PubMed ID: 33632058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into disease mechanisms and potential therapeutics for C9orf72-related amyotrophic lateral sclerosis/frontotemporal dementia.
    Gagliardi D; Costamagna G; Taiana M; Andreoli L; Biella F; Bersani M; Bresolin N; Comi GP; Corti S
    Ageing Res Rev; 2020 Dec; 64():101172. PubMed ID: 32971256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA-mediated toxicity in C9orf72 ALS and FTD.
    McEachin ZT; Parameswaran J; Raj N; Bassell GJ; Jiang J
    Neurobiol Dis; 2020 Nov; 145():105055. PubMed ID: 32829028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Mechanisms of Neurodegeneration Related to
    Babić Leko M; Župunski V; Kirincich J; Smilović D; Hortobágyi T; Hof PR; Šimić G
    Behav Neurol; 2019; 2019():2909168. PubMed ID: 30774737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C9orf72 amyotrophic lateral sclerosis and frontotemporal dementia: gain or loss of function?
    Mizielinska S; Isaacs AM
    Curr Opin Neurol; 2014 Oct; 27(5):515-23. PubMed ID: 25188012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease Mechanisms of
    Gendron TF; Petrucelli L
    Cold Spring Harb Perspect Med; 2018 Apr; 8(4):. PubMed ID: 28130314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glial Cell Dysfunction in
    Ghasemi M; Keyhanian K; Douthwright C
    Cells; 2021 Jan; 10(2):. PubMed ID: 33525344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retention of hexanucleotide repeat-containing intron in C9orf72 mRNA: implications for the pathogenesis of ALS/FTD.
    Niblock M; Smith BN; Lee YB; Sardone V; Topp S; Troakes C; Al-Sarraj S; Leblond CS; Dion PA; Rouleau GA; Shaw CE; Gallo JM
    Acta Neuropathol Commun; 2016 Feb; 4():18. PubMed ID: 26916632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Therapeutics for C9ORF72 ALS/FTD-Related Disorders.
    Mis MSC; Brajkovic S; Tafuri F; Bresolin N; Comi GP; Corti S
    Mol Neurobiol; 2017 Aug; 54(6):4466-4476. PubMed ID: 27349438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice.
    Peters OM; Cabrera GT; Tran H; Gendron TF; McKeon JE; Metterville J; Weiss A; Wightman N; Salameh J; Kim J; Sun H; Boylan KB; Dickson D; Kennedy Z; Lin Z; Zhang YJ; Daughrity L; Jung C; Gao FB; Sapp PC; Horvitz HR; Bosco DA; Brown SP; de Jong P; Petrucelli L; Mueller C; Brown RH
    Neuron; 2015 Dec; 88(5):902-909. PubMed ID: 26637797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C9orf72-mediated ALS and FTD: multiple pathways to disease.
    Balendra R; Isaacs AM
    Nat Rev Neurol; 2018 Sep; 14(9):544-558. PubMed ID: 30120348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergence, Convergence, and Therapeutic Implications: A Cell Biology Perspective of C9ORF72-ALS/FTD.
    Tang X; Toro A; T G S; Gao J; Chalk J; Oskarsson B; Zhang K
    Mol Neurodegener; 2020 Jun; 15(1):34. PubMed ID: 32513219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-depth clinico-pathological examination of RNA foci in a large cohort of C9ORF72 expansion carriers.
    DeJesus-Hernandez M; Finch NA; Wang X; Gendron TF; Bieniek KF; Heckman MG; Vasilevich A; Murray ME; Rousseau L; Weesner R; Lucido A; Parsons M; Chew J; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Boeve BF; Graff-Radford NR; de Boer J; Asmann YW; Petrucelli L; Boylan KB; Dickson DW; van Blitterswijk M; Rademakers R
    Acta Neuropathol; 2017 Aug; 134(2):255-269. PubMed ID: 28508101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic determinants and mechanisms of ALS/FTD linked to hexanucleotide repeat expansions in the C9orf72 gene.
    Wen X; Westergard T; Pasinelli P; Trotti D
    Neurosci Lett; 2017 Jan; 636():16-26. PubMed ID: 27619540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C9orf72 Hexanucleotide Expansions Are Associated with Altered Endoplasmic Reticulum Calcium Homeostasis and Stress Granule Formation in Induced Pluripotent Stem Cell-Derived Neurons from Patients with Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
    Dafinca R; Scaber J; Ababneh N; Lalic T; Weir G; Christian H; Vowles J; Douglas AG; Fletcher-Jones A; Browne C; Nakanishi M; Turner MR; Wade-Martins R; Cowley SA; Talbot K
    Stem Cells; 2016 Aug; 34(8):2063-78. PubMed ID: 27097283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the C9ORF72 Gene in the Pathogenesis of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
    Hao Z; Wang R; Ren H; Wang G
    Neurosci Bull; 2020 Sep; 36(9):1057-1070. PubMed ID: 32860626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions.
    Simón-Sánchez J; Dopper EG; Cohn-Hokke PE; Hukema RK; Nicolaou N; Seelaar H; de Graaf JR; de Koning I; van Schoor NM; Deeg DJ; Smits M; Raaphorst J; van den Berg LH; Schelhaas HJ; De Die-Smulders CE; Majoor-Krakauer D; Rozemuller AJ; Willemsen R; Pijnenburg YA; Heutink P; van Swieten JC
    Brain; 2012 Mar; 135(Pt 3):723-35. PubMed ID: 22300876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How villains are made: The translation of dipeptide repeat proteins in C9ORF72-ALS/FTD.
    Van't Spijker HM; Almeida S
    Gene; 2023 Mar; 858():147167. PubMed ID: 36621656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. There has been an awakening: Emerging mechanisms of C9orf72 mutations in FTD/ALS.
    Gitler AD; Tsuiji H
    Brain Res; 2016 Sep; 1647():19-29. PubMed ID: 27059391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.